Guidelines for the Laboratory Diagnosis of Monkeypox in Korea
While the coronavirus disease 2019 pandemic is ongoing, monkeypox has been rapidly spreading in non-endemic countries since May 2022. Accurate and rapid laboratory tests are essential for identifying and controlling monkeypox. Korean Society for Laboratory Medicine and the Korea Disease Prevention and Control Agency have proposed guidelines for diagnosing monkeypox in clinical laboratories in Korea. These guidelines cover the type of tests, selection of specimens, collection of specimens, diagnostic methods, interpretation of test results, and biosafety. Molecular tests are recommended as confirmatory tests. Skin lesion specimens are recommended for testing in the symptomatic stage, and the collection of both blood and oropharyngeal swabs is recommended in the presymptomatic or prodromal stage.
| Errataetall: |
CommentIn: Ann Lab Med. 2023 Mar 1;43(2):135-136. - PMID 36281506 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Annals of laboratory medicine - 43(2023), 2 vom: 01. März, Seite 137-144 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Hong, Ki Ho [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 26.10.2022 Date Revised 13.12.2023 published: Print-Electronic CommentIn: Ann Lab Med. 2023 Mar 1;43(2):135-136. - PMID 36281506 Citation Status MEDLINE |
|---|
| doi: |
10.3343/alm.2023.43.2.137 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM347960774 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM347960774 | ||
| 003 | DE-627 | ||
| 005 | 20231227130955.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3343/alm.2023.43.2.137 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1225.xml |
| 035 | |a (DE-627)NLM347960774 | ||
| 035 | |a (NLM)36281507 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Hong, Ki Ho |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Guidelines for the Laboratory Diagnosis of Monkeypox in Korea |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 26.10.2022 | ||
| 500 | |a Date Revised 13.12.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentIn: Ann Lab Med. 2023 Mar 1;43(2):135-136. - PMID 36281506 | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a While the coronavirus disease 2019 pandemic is ongoing, monkeypox has been rapidly spreading in non-endemic countries since May 2022. Accurate and rapid laboratory tests are essential for identifying and controlling monkeypox. Korean Society for Laboratory Medicine and the Korea Disease Prevention and Control Agency have proposed guidelines for diagnosing monkeypox in clinical laboratories in Korea. These guidelines cover the type of tests, selection of specimens, collection of specimens, diagnostic methods, interpretation of test results, and biosafety. Molecular tests are recommended as confirmatory tests. Skin lesion specimens are recommended for testing in the symptomatic stage, and the collection of both blood and oropharyngeal swabs is recommended in the presymptomatic or prodromal stage | ||
| 650 | 4 | |a Guideline | |
| 650 | 4 | |a Guidelines | |
| 650 | 4 | |a Korea | |
| 650 | 4 | |a Laboratory diagnosis | |
| 650 | 4 | |a Monkeypox | |
| 650 | 4 | |a PCR | |
| 700 | 1 | |a Kim, Gab Jung |e verfasserin |4 aut | |
| 700 | 1 | |a Roh, Kyoung Ho |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Hyukmin |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Ok Kyu |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Taek Soo |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Jae-Seok |e verfasserin |4 aut | |
| 700 | 1 | |a Lee, Jaehyeon |e verfasserin |4 aut | |
| 700 | 1 | |a Seong, Moon-Woo |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, So Yeon |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Jae-Sun |e verfasserin |4 aut | |
| 700 | 1 | |a Park, Younhee |e verfasserin |4 aut | |
| 700 | 1 | |a Huh, Hee Jae |e verfasserin |4 aut | |
| 700 | 1 | |a Ryoo, Namhee |e verfasserin |4 aut | |
| 700 | 1 | |a Kim, Hyun Soo |e verfasserin |4 aut | |
| 700 | 1 | |a Sung, Heungsup |e verfasserin |4 aut | |
| 700 | 1 | |a Yoo, Cheon Kwon |e verfasserin |4 aut | |
| 700 | 0 | |a Committee of Management of Laboratory Tests for Infectious Diseases, Korean Society for Laboratory Medicine |e verfasserin |4 aut | |
| 700 | 0 | |a Bureau of Infectious Disease Diagnosis Control, Korea Disease Control and Prevention Agency |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annals of laboratory medicine |d 2012 |g 43(2023), 2 vom: 01. März, Seite 137-144 |w (DE-627)NLM215937082 |x 2234-3814 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2023 |g number:2 |g day:01 |g month:03 |g pages:137-144 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.3343/alm.2023.43.2.137 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2023 |e 2 |b 01 |c 03 |h 137-144 | ||